Department of Acupuncture & Moxibustion Medicine, College of Korean Medicine, Gachon University, Seongnam, Republic of Korea.
Department of Acupuncture & Moxibustion Medicine, College of Korean Medicine, Sangji University.
Medicine (Baltimore). 2021 Feb 12;100(6):e24719. doi: 10.1097/MD.0000000000024719.
Hyperuricemia (HUA) plays an important role in metabolic syndrome, cardiovascular disease, and kidney disease. HUA without resulting gout is referred to as asymptomatic HUA. The purpose of the present systematic review protocol is to provide methods to assess the effectiveness and safety of acupuncture-based treatment for asymptomatic HUA.
To identify randomized controlled trials (RCTs) involving acupuncture-based treatment for asymptomatic HUA, a search will be carried out using the following eight electronic databases: MEDLINE, EMBASE, Cochrane Library, Korea Med, Oriental Medicine Advanced Searching Integrated System, Korean Studies Information Service System, China National Knowledge Infrastructure, and Japanese Institutional Repositories Online. Manual search and email contact with the author will also be conducted if necessary. Studies will be selected based on predefined criteria and summarized data regarding study participants, interventions, control groups, outcome measures, side effects, and risk of bias. No language restrictions will be imposed. Studies that evaluated any type of acupuncture will be eligible for inclusion, and the primary outcome will be the blood uric acid level. The methodological quality of the included RCTs will be assessed using the Cochrane risk of bias tool.
The present study will evaluate the efficacy and safety of acupuncture to treat HUA.
Our findings will establish the evidence for acupuncture-based treatment of HUA and will be informative for patients with HUA, clinicians, policy makers, and researchers.
reviewregistry1054.
高尿酸血症(HUA)在代谢综合征、心血管疾病和肾脏疾病中起着重要作用。没有导致痛风的 HUA 被称为无症状 HUA。本系统评价方案的目的是提供评估基于针刺的治疗无症状 HUA 的有效性和安全性的方法。
为了确定涉及基于针刺的无症状 HUA 治疗的随机对照试验(RCT),将使用以下八个电子数据库进行搜索:MEDLINE、EMBASE、Cochrane 图书馆、韩国医学、东方医学高级搜索集成系统、韩国研究信息服务系统、中国国家知识基础设施和日本机构知识库在线。如有必要,还将进行手动搜索和与作者的电子邮件联系。将根据预先确定的标准选择研究,并总结有关研究参与者、干预措施、对照组、结局测量、副作用和偏倚风险的数据。不施加语言限制。将评估任何类型的针刺的研究纳入,主要结局将是血尿酸水平。将使用 Cochrane 偏倚风险工具评估纳入的 RCT 的方法学质量。
本研究将评估针刺治疗 HUA 的疗效和安全性。
我们的研究结果将为基于针刺的 HUA 治疗提供证据,并为 HUA 患者、临床医生、决策者和研究人员提供信息。
reviewregistry1054。